TransMedics (TMDX) Operating Leases (2021 - 2026)

TransMedics has reported Operating Leases for 6 years, with the latest figure at $2.9 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases fell 47.78% year-over-year to $2.9 million; the trailing twelve-month figure through Mar 2026 stood at $2.9 million (down 47.78% YoY), and the FY2025 full-year result was $3.6 million, down 42.76% from the prior year.
• Operating Leases for Q1 2026 stood at $2.9 million, down from $3.6 million in the prior quarter.
• The five-year high for Operating Leases was $8.5 million in Q1 2022, with the low at $2.9 million in Q1 2026.
• Average Operating Leases over 5 years is $6.6 million, with a median of $7.1 million recorded in 2024.
• Year-over-year, Operating Leases increased 5.71% in 2023 and tumbled 47.78% in 2026.
• Tracing TMDX's Operating Leases over 5 years: stood at $7.4 million in 2022, then gained by 3.94% to $7.7 million in 2023, then fell by 18.92% to $6.2 million in 2024, then tumbled by 42.76% to $3.6 million in 2025, then slipped by 19.4% to $2.9 million in 2026.
• The last three Operating Leases figures came in at $2.9 million (Q1 2026), $3.6 million (Q4 2025), and $4.4 million (Q3 2025), per Business Quant data.

Peer Comparison